{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T09:12:55Z","timestamp":1772183575543,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jcrc.2018.10.019","type":"journal-article","created":{"date-parts":[[2018,10,28]],"date-time":"2018-10-28T17:17:46Z","timestamp":1540747066000},"page":"179-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Neuromuscular blocking agents for acute respiratory distress syndrome"],"prefix":"10.1016","volume":"49","author":[{"given":"Heather","family":"Torbic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4220-2359","authenticated-orcid":false,"given":"Abhijit","family":"Duggal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jcrc.2018.10.019_bb0005","first-page":"1","article-title":"Current incidence and outcome of the acute respiratory distress syndrome","volume":"22","author":"Villar","year":"2016","journal-title":"Curr. Opin. Crit. Care"},{"issue":"8","key":"10.1016\/j.jcrc.2018.10.019_bb0010","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2016.0291","article-title":"Epidemiology, patterns of Care, and Mortality for patients with Acute respiratory Distress Syndrome in Intensive Care units in 50 Countries","volume":"315","author":"Bellani","year":"2016","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jcrc.2018.10.019_bb0015","doi-asserted-by":"crossref","first-page":"440","DOI":"10.7326\/0003-4819-141-6-200409210-00009","article-title":"Comparison of clinical criteria for the acute respiratory distress syndrome with autopsy findings","volume":"141","author":"Esteban","year":"2004","journal-title":"Ann. Intern. Med."},{"issue":"7","key":"10.1016\/j.jcrc.2018.10.019_bb0020","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1164\/rccm.201211-1981OC","article-title":"Comparison of the Berlin definition for acute respiratory distress syndrome with autopsy","volume":"187","author":"Thille","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.jcrc.2018.10.019_bb0025","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1056\/NEJMra1608077","article-title":"Acute respiratory distress syndrome","volume":"377","author":"Thompson","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.jcrc.2018.10.019_bb0030","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.201703-0548ST","article-title":"An Official American Thoracic Society\/European Society of Intensive Care Medicine\/Society of Critical Care Medicine Clinical Practice Guideline: Mechanical Ventilation in Adult patients with acute respiratory distress syndrome","volume":"195","author":"Fan","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"12","key":"10.1016\/j.jcrc.2018.10.019_bb0035","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1056\/NEJMoa1005372","article-title":"Neuromuscular blockers in early acute respiratory distress syndrome","volume":"363","author":"Papazian","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jcrc.2018.10.019_bb0040","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jama.280.2.159","article-title":"Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial","volume":"280","author":"Meduri","year":"1998","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.jcrc.2018.10.019_bb0045","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1378\/chest.06-2100","article-title":"Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial","volume":"131","author":"Meduri","year":"2007","journal-title":"Chest"},{"issue":"16","key":"10.1016\/j.jcrc.2018.10.019_bb0050","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa051693","article-title":"Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome","volume":"354","author":"Steinberg","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.jcrc.2018.10.019_bb0055","first-page":"567","article-title":"Pharmacological treatments for acute respiratory distress syndrome: systematic review","volume":"81","author":"Duggal","year":"2015","journal-title":"Minerva Anestesiol."},{"issue":"12","key":"10.1016\/j.jcrc.2018.10.019_bb0060","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1056\/NEJMe1007136","article-title":"Neuromuscular blocking agents in ARDS","volume":"363","author":"Slutsky","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.jcrc.2018.10.019_bb0065","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1007\/s00134-015-4040-6","article-title":"Prone positioning and neuromuscular blocking agents are part of standard care in severe ARDS patients: we are not sure","volume":"41","author":"Gattinoni","year":"2015","journal-title":"Intensive Care Med."},{"issue":"5","key":"10.1016\/j.jcrc.2018.10.019_bb0070","first-page":"495","article-title":"The role of neuromuscular blockers in ARDS: benefits and risks","volume":"18","author":"Hraiech","year":"2012","journal-title":"Curr. Opin. Crit. Care"},{"issue":"3","key":"10.1016\/j.jcrc.2018.10.019_bb0075","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00134-016-4653-4","article-title":"Effects of neuromuscular blockers on transpulmonary pressures in moderate to severe acute respiratory distress syndrome","volume":"43","author":"Guervilly","year":"2017","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.jcrc.2018.10.019_bb0080","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00003246-199001000-00022","article-title":"Physiologic approach to mechanical ventilation","volume":"18","author":"Hubmayr","year":"1990","journal-title":"Crit. Care Med."},{"issue":"10","key":"10.1016\/j.jcrc.2018.10.019_bb0085","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/bja\/28.10.470","article-title":"Mode of action of neuromuscular blocking agents","volume":"28","author":"Paton","year":"1956","journal-title":"Br. J. Anaesth."},{"issue":"1","key":"10.1016\/j.jcrc.2018.10.019_bb0090","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/01.CCM.0000104114.72614.BC","article-title":"Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome","volume":"32","author":"Gainnier","year":"2004","journal-title":"Crit. Care Med."},{"issue":"11","key":"10.1016\/j.jcrc.2018.10.019_bb0095","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1097\/01.CCM.0000239435.87433.0D","article-title":"Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome","volume":"34","author":"Forel","year":"2006","journal-title":"Crit. Care Med."},{"issue":"14","key":"10.1016\/j.jcrc.2018.10.019_bb0100","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/rcm.1290091425","article-title":"Identification of urinary and biliary conjugated metabolites of the neuromuscular blocker 51W89 by liquid chromatography\/mass spectrometry","volume":"9","author":"Dear","year":"1995","journal-title":"Rapid Commun. Mass Spectrom.: RCM"},{"issue":"7","key":"10.1016\/j.jcrc.2018.10.019_bb0105","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/00003643-200207000-00002","article-title":"Laudanosine, an atracurium and cisatracurium metabolite","volume":"19","author":"Fodale","year":"2002","journal-title":"Eur. J. Anaesthesiol."},{"key":"10.1016\/j.jcrc.2018.10.019_bb0110","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1399-6576.1995.tb04317.x","article-title":"The future of the benzylisoquinolinium relaxants","volume":"106","author":"Savarese","year":"1995","journal-title":"Acta Anaesthesiol. Scand. Suppl."},{"issue":"5","key":"10.1016\/j.jcrc.2018.10.019_bb0115","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1093\/bja\/75.5.588","article-title":"Histamine-release haemodynamic changes produced by rocuronium, vecuronium, mivacurium, atracurium and tubocurarine","volume":"75","author":"Naguib","year":"1995","journal-title":"Br. J. Anaesth."},{"issue":"7","key":"10.1016\/j.jcrc.2018.10.019_bb0120","doi-asserted-by":"crossref","first-page":"947","DOI":"10.4187\/respcare.05102","article-title":"Comparison of cisatracurium versus atracurium in early ARDS","volume":"62","author":"Moore","year":"2017","journal-title":"Respir. Care"},{"issue":"7","key":"10.1016\/j.jcrc.2018.10.019_bb0125","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1164\/rccm.201706-1132OC","article-title":"An Observational Study of the Efficacy of Cisatracurium compared with vecuronium in patients with or at risk for acute respiratory distress syndrome","volume":"197","author":"Sottile","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.jcrc.2018.10.019_bb0130","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/2110-5820-2-43","article-title":"A fresh look at paralytics in the critically ill: real promise and real concern","volume":"2","author":"Price","year":"2012","journal-title":"Ann. Intensive Care"},{"issue":"4","key":"10.1016\/j.jcrc.2018.10.019_bb0135","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1097\/CCM.0B013E3181653895","article-title":"Use of sedatives, opioids, and neuromuscular blocking agents in patients with acute lung injury and acute respiratory distress syndrome","volume":"36","author":"Arroliga","year":"2008","journal-title":"Crit. Care Med."},{"issue":"7","key":"10.1016\/j.jcrc.2018.10.019_bb0140","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1513\/AnnalsATS.201508-560OC","article-title":"Refractory hypoxemia and use of rescue strategies. A U.S. National Survey of Adult Intensivists","volume":"13","author":"Alhurani","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"11","key":"10.1016\/j.jcrc.2018.10.019_bb0145","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1097\/CCM.0000000000002027","article-title":"Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient","volume":"44","author":"Murray","year":"2016","journal-title":"Crit. Care Med."},{"issue":"3 Pt 1","key":"10.1016\/j.jcrc.2018.10.019_bb0150","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/ajrccm.149.3.7509706","article-title":"The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination","volume":"149","author":"Bernard","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.jcrc.2018.10.019_bb0155","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1513\/AnnalsATS.201608-629OT","article-title":"Design and rationale of the reevaluation of systemic early neuromuscular blockade trial for acute respiratory distress syndrome","volume":"14","author":"Huang","year":"2017","journal-title":"Ann Am Thorac Soc"},{"issue":"23","key":"10.1016\/j.jcrc.2018.10.019_bb0160","first-page":"2526","article-title":"Acute respiratory distress syndrome: the Berlin definition","volume":"307","author":"Ranieri","year":"2012","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jcrc.2018.10.019_bb0165","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1164\/ajrccm.156.5.9701079","article-title":"Comparison of train-of-four and best clinical assessment during continuous paralysis","volume":"156","author":"Strange","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.jcrc.2018.10.019_bb0170","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00003246-199704000-00005","article-title":"A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients","volume":"25","author":"Rudis","year":"1997","journal-title":"Crit. Care Med."},{"issue":"4","key":"10.1016\/j.jcrc.2018.10.019_bb0175","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1378\/chest.126.4.1267","article-title":"A prospective randomized comparison of train-of-four monitoring and clinical assessment during continuous ICU cisatracurium paralysis","volume":"126","author":"Baumann","year":"2004","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.jcrc.2018.10.019_bb0180","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00134-002-1508-y","article-title":"A comparison of two depths of prolonged neuromuscular blockade induced by cisatracurium in mechanically ventilated critically ill patients","volume":"28","author":"Lagneau","year":"2002","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.jcrc.2018.10.019_bb0185","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13613-017-0305-2","article-title":"How to reduce cisatracurium consumption in ARDS patients: the TOF-ARDS study","volume":"7","author":"Hraiech","year":"2017","journal-title":"Ann. Intensive Care"},{"key":"10.1016\/j.jcrc.2018.10.019_bb0190","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jcrc.2016.11.040","article-title":"Perceived safety and efficacy of neuromuscular blockers for acute respiratory distress syndrome among medical intensive care unit practitioners: a multicenter survey","volume":"38","author":"Torbic","year":"2017","journal-title":"J. Crit. Care"},{"issue":"3","key":"10.1016\/j.jcrc.2018.10.019_bb0195","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ccm.2018.04.002","article-title":"Prevention of deep vein thrombosis and pulmonary embolism in high-risk medical patients","volume":"39","author":"McCullough","year":"2018","journal-title":"Clin. Chest Med."},{"issue":"1","key":"10.1016\/j.jcrc.2018.10.019_bb0200","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1538-7836.2009.03664.x","article-title":"Reduction in deep vein thrombosis incidence in intensive care after a clinician education program","volume":"8","author":"Boddi","year":"2010","journal-title":"J. Thromb. Haemost.: JTH"},{"issue":"12","key":"10.1016\/j.jcrc.2018.10.019_bb0205","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1097\/CCM.0b013e31818f0ee7","article-title":"Eye care in the intensive care unit: narrative review and meta-analysis","volume":"36","author":"Rosenberg","year":"2008","journal-title":"Crit. Care Med."},{"issue":"5","key":"10.1016\/j.jcrc.2018.10.019_bb0210","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1097\/CCM.0b013e31828ce07c","article-title":"The use of neuromuscular blocking agents in the ICU: where are we now?","volume":"41","author":"Greenberg","year":"2013","journal-title":"Crit. Care Med."},{"issue":"23","key":"10.1016\/j.jcrc.2018.10.019_bb0215","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1093\/ajhp\/58.23.2287","article-title":"Neuromuscular blockers in surgery and intensive care, part 1","volume":"58","author":"McManus","year":"2001","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"10","key":"10.1016\/j.jcrc.2018.10.019_bb0220","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S1474-4422(11)70178-8","article-title":"Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis","volume":"10","author":"Latronico","year":"2011","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.jcrc.2018.10.019_bb0225","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1378\/chest.99.1.176","article-title":"Peripheral nerve function in sepsis and multiple organ failure","volume":"99","author":"Witt","year":"1991","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.jcrc.2018.10.019_bb0230","first-page":"126","article-title":"Critical illness myopathy and neuropathy","volume":"11","author":"Latronico","year":"2005","journal-title":"Curr. Opin. Crit. Care"},{"issue":"4","key":"10.1016\/j.jcrc.2018.10.019_bb0235","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ccm.2014.08.012","article-title":"The use of paralytics in patients with acute respiratory distress syndrome","volume":"35","author":"Hraiech","year":"2014","journal-title":"Clin. Chest Med."},{"issue":"12","key":"10.1016\/j.jcrc.2018.10.019_bb0240","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1097\/CCM.0b013e3181b027e9","article-title":"Presence and severity of intensive care unit-acquired paresis at time of awakening are associated with increased intensive care unit and hospital mortality","volume":"37","author":"Sharshar","year":"2009","journal-title":"Crit. Care Med."},{"issue":"3","key":"10.1016\/j.jcrc.2018.10.019_bb0245","doi-asserted-by":"crossref","first-page":"R119","DOI":"10.1186\/cc9074","article-title":"Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study","volume":"14","author":"Weber-Carstens","year":"2010","journal-title":"Crit. Care (London, England)"},{"issue":"1","key":"10.1016\/j.jcrc.2018.10.019_bb0250","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1164\/ajrccm\/147.1.234","article-title":"Neuromuscular blockade in the intensive care unit. More than we bargained for","volume":"147","author":"Hansen-Flaschen","year":"1993","journal-title":"Am. Rev. Respir. Dis."},{"issue":"3","key":"10.1016\/j.jcrc.2018.10.019_bb0255","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/CCM.0b013e3181cc4b53","article-title":"Intensive care unit-acquired weakness","volume":"38","author":"Griffiths","year":"2010","journal-title":"Crit. Care Med."},{"issue":"2","key":"10.1016\/j.jcrc.2018.10.019_bb0260","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/j.1875-9114.1998.tb03862.x","article-title":"Patient recall of therapeutic paralysis in a surgical critical care unit","volume":"18","author":"Wagner","year":"1998","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.jcrc.2018.10.019_bb0265","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4037\/ajcc2006.15.1.86","article-title":"Patients' recollections of therapeutic paralysis in the intensive care unit","volume":"15","author":"Ballard","year":"2006","journal-title":"Am. J. Crit. Care"},{"issue":"1","key":"10.1016\/j.jcrc.2018.10.019_bb0270","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4037\/ajcc1999.8.1.490","article-title":"Therapeutic paralysis of critically ill trauma patients: perceptions of patients and their family members","volume":"8","author":"Johnson","year":"1999","journal-title":"Am. J. Crit. Care"},{"issue":"3","key":"10.1016\/j.jcrc.2018.10.019_bb0275","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/0885066603251200","article-title":"National survey of the use of sedating drugs, neuromuscular blocking agents, and reversal agents in the intensive care unit","volume":"18","author":"Rhoney","year":"2003","journal-title":"J. Intensive Care Med."},{"issue":"3","key":"10.1016\/j.jcrc.2018.10.019_bb0280","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0304-3959(89)90196-6","article-title":"Paralyzed with pain: the need for education","volume":"37","author":"Loper","year":"1989","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.jcrc.2018.10.019_bb0285","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00134-005-0031-3","article-title":"Effects of neuromuscular block on systemic and cerebral hemodynamics and bispectral index during moderate or deep sedation in critically ill patients","volume":"32","author":"Inoue","year":"2006","journal-title":"Intensive Care Med."}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944118308268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944118308268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:38:52Z","timestamp":1760125132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944118308268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":57,"alternative-id":["S0883944118308268"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2018.10.019","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuromuscular blocking agents for acute respiratory distress syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2018.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}